Dongliang Xu Selected Research

Neoplasms (Cancer)

4/2024	Bisphenol S enhances the cell proliferation ability of prostate cancer cells by regulating the expression of SDS.
1/2024	PIGT promotes cell growth, glycolysis, and metastasis in bladder cancer by modulating GLUT1 glycosylation and membrane trafficking.
12/2023	CHKB-AS1 enhances proliferation and resistance to NVP-BEZ235 of renal cancer cells via regulating the phosphorylation of MAP4 and PI3K/AKT/mTOR signaling.
11/2023	Super-enhancer-associated SNHG15 cooperating with FOSL1 contributes to bladder cancer progression through the WNT pathway.
10/2023	NF-κB represses retinoic acid receptor-mediated GPRC5A transactivation in lung epithelial cells to promote neoplasia.
1/2023	Identification of the novel therapeutic targets and biomarkers associated of prostate cancer with cancer-associated fibroblasts (CAFs).
1/2023	Molecular Targets of Shenqi Dihuang, A Traditional Chinese Herbal Medicine, and Its Potential Role in Renal Cell Carcinoma Therapy.
1/2023	TLimmuno2: predicting MHC class II antigen immunogenicity through transfer learning.
1/2022	Identification of Active Bronchioalveolar Stem Cells as the Cell of Origin in Lung Adenocarcinoma.
1/2022	Identifying tumor antigens and immune subtypes of renal cell carcinoma for immunotherapy development.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dongliang Xu Research Topics

Disease

28	Neoplasms (Cancer) 04/2024 - 10/2014
12	Neoplasm Metastasis (Metastasis) 01/2024 - 10/2014
10	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 01/2015
8	Carcinogenesis 01/2024 - 11/2015
8	Lung Neoplasms (Lung Cancer) 01/2021 - 05/2015
7	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 01/2013
4	Wounds and Injuries (Trauma) 07/2022 - 11/2011
3	Renal Cell Carcinoma (Grawitz Tumor) 12/2023 - 01/2022
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 05/2015
3	Infections 09/2022 - 09/2004
3	Adenocarcinoma of Lung 01/2022 - 01/2019
3	Squamous Cell Carcinoma of Head and Neck 05/2017 - 03/2015
2	Periprosthetic Fractures 09/2022 - 09/2012
2	Hemorrhage 12/2020 - 11/2011
2	Hyperplasia 08/2019 - 11/2015
2	Non-Muscle Invasive Bladder Neoplasms 02/2019 - 06/2017
2	Osteoarthritis 07/2018 - 07/2017
2	Acute Lung Injury 11/2015 - 01/2015
1	Breast Neoplasms (Breast Cancer) 04/2024
1	Wilms Tumor (Wilm's Tumor) 01/2024
1	Kidney Neoplasms (Kidney Cancer) 12/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2022
1	Angiomyolipoma 01/2021
1	Osteonecrosis (Kienbock's Disease) 01/2021
1	Postoperative Hemorrhage 12/2020
1	Thrombosis (Thrombus) 12/2020
1	Hematoma 12/2020
1	Ecchymosis 12/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2020
1	Pulmonary Embolism 07/2020

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2010
4	Messenger RNA (mRNA)IBA 01/2024 - 01/2013
4	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2016
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2023 - 05/2015
3	AntigensIBA 01/2023 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2017
2	p38 Mitogen-Activated Protein KinasesIBA 04/2022 - 11/2017
2	Dinoprostone (PGE2)FDA Link 01/2020 - 01/2019
2	CytokinesIBA 01/2020 - 01/2015
2	Epidermal Growth Factor (EGF)IBA 08/2019 - 05/2015
2	ThuliumIBA 02/2019 - 06/2017
2	nutlin 3IBA 01/2019 - 01/2019
2	Small Interfering RNA (siRNA)IBA 01/2019 - 10/2014
2	EndotoxinsIBA 11/2015 - 01/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2015 - 11/2011
2	celastrol methyl esterIBA 03/2015 - 01/2015
1	bis(4-hydroxyphenyl)sulfoneIBA 04/2024
1	bisphenol AIBA 04/2024
1	Carrier Proteins (Binding Protein)IBA 01/2024
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2024
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2024
1	6-methyladenineIBA 01/2024
1	Insulin-Like PeptidesIBA 01/2024
1	dactolisibIBA 12/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2023
1	tanshinoneIBA 11/2023
1	Small Nucleolar RNA (snoRNA)IBA 11/2023
1	Transcription Factors (Transcription Factor)IBA 11/2023
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 10/2023
1	Insulin (Novolin)FDA Link 01/2023
1	AdipokinesIBA 01/2023
1	VaccinesIBA 01/2023
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2023
1	shenqiIBA 01/2023
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2023
1	CB2 Cannabinoid ReceptorIBA 04/2022
1	CannabinoidsIBA 04/2022
1	schizandrin BIBA 04/2022
1	LignansIBA 04/2022
1	mRNA VaccinesIBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	AcidsIBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	ZeolitesIBA 01/2021
1	IntegrinsIBA 01/2021
1	Glutathione (Reduced Glutathione)IBA 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021
1	Epoxide HydrolasesIBA 01/2021
1	Cystine (L-Cystine)IBA 01/2021
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2021
1	BuffersIBA 01/2021
1	AnticoagulantsIBA 12/2020
1	Hemoglobins (Hemoglobin)IBA 12/2020
1	Nadroparin (Nadroparin Calcium)IBA 12/2020
1	Hemostatics (Antihemorrhagics)IBA 07/2020
1	HexokinaseIBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020

Therapy/Procedure

8	Therapeutics 12/2023 - 10/2014
3	Prostheses and Implants (Prosthesis) 09/2022 - 11/2011
2	Immunotherapy 01/2023 - 01/2022
2	Nephrectomy 01/2021 - 10/2017
2	Transurethral Resection of Bladder 08/2019 - 02/2019
2	Lasers (Laser) 02/2019 - 06/2017
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2023
1	Anterior Cruciate Ligament Reconstruction 07/2022
1	Photothermal Therapy 01/2021
1	Castration 01/2021
1	Vacuum Curettage 01/2021
1	Blood Transfusion (Blood Transfusions) 12/2020
1	Length of Stay 07/2020